Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity.
about
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.A bioavailable cathepsin S nitrile inhibitor abrogates tumor development.
P2860
Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nanoencapsulation of ABT-737 a ...... eduction of systemic toxicity.
@ast
Nanoencapsulation of ABT-737 a ...... eduction of systemic toxicity.
@en
type
label
Nanoencapsulation of ABT-737 a ...... eduction of systemic toxicity.
@ast
Nanoencapsulation of ABT-737 a ...... eduction of systemic toxicity.
@en
prefLabel
Nanoencapsulation of ABT-737 a ...... eduction of systemic toxicity.
@ast
Nanoencapsulation of ABT-737 a ...... eduction of systemic toxicity.
@en
P2093
P2860
P50
P356
P1476
Nanoencapsulation of ABT-737 a ...... eduction of systemic toxicity.
@en
P2093
D B Longley
M K Greene
P G Johnston
P2860
P2888
P356
10.1038/CDDIS.2014.413
P577
2014-10-09T00:00:00Z
P5875
P6179
1037067922